Osteoporosis classification scheme: Difference between revisions
m Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,... |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Osteoporosis}} | {{Osteoporosis}} | ||
{{CMG}} | {{CMG}}; '''Associate Editor(s)-In-Chief:''' {{CZ}}, [[User:Raviteja Reddy Guddeti|Raviteja Guddeti, M.B.B.S.]][mailto:ravitheja.g@gmail.com] | ||
'''Associate Editor(s)-In-Chief:''' {{CZ}}, [[User:Raviteja Reddy Guddeti|Raviteja Guddeti, M.B.B.S.]][mailto: | |||
==Overview== | ==Overview== | ||
| Line 15: | Line 14: | ||
There is a spectrum of disease ranging from osteopenia (milder and earlier bone loss) to osteoporosis (later more severe bone loss). | There is a spectrum of disease ranging from osteopenia (milder and earlier bone loss) to osteoporosis (later more severe bone loss). | ||
===Osteopenia=== | ===Osteopenia=== | ||
'''Osteopenia''' which is defined as [[bone mineral density]] ranging from less than -1.0 and more than -2.5, can be a precursor condition to [[osteoporosis]].<ref name="WHOcriteria">{{cite web |author=WHO Scientific Group on the Prevention and Management of Osteoporosis (2000 : Geneva, Switzerland)|url=http://whqlibdoc.who.int/trs/WHO_TRS_921.pdf |title=Prevention and management of osteoporosis : report of a WHO scientific group|year=2003 |accessdate=2007-05-31 |format=pdf |work=}}</ref> | '''Osteopenia''' which is defined as [[bone mineral density]] ranging from less than -1.0 and more than -2.5, can be a precursor condition to [[osteoporosis]].<ref name="WHOcriteria">{{cite web |author=WHO Scientific Group on the Prevention and Management of Osteoporosis (2000 : Geneva, Switzerland)|url=http://whqlibdoc.who.int/trs/WHO_TRS_921.pdf |title=Prevention and management of osteoporosis : report of a WHO scientific group|year=2003 |accessdate=2007-05-31 |format=pdf |work=}}</ref> | ||
===Osteoporosis=== | ===Osteoporosis=== | ||
In osteoporosis the [[bone mineral density]] (BMD) is reduced, bone microarchitecture is disrupted, and the amount and variety of non-[[collagen]]ous proteins in bone is altered. Osteoporosis is defined by the [[World Health Organization]] (WHO) in women as a bone mineral density 2.5 [[standard deviation]]s below peak bone mass (20-year-old sex-matched healthy person average) as measured by [[Dual energy X-ray absorptiometry|DXA]]; the term "established osteoporosis" includes the presence of a [[fragility fracture]].<ref name=WHO1994>{{cite journal |author=WHO |title=Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group |journal=World Health Organization technical report series |volume=843|issue= |pages=1–129 |year=1994 |pmid=7941614 |doi=}}</ref> | In osteoporosis the [[bone mineral density]] (BMD) is reduced, bone microarchitecture is disrupted, and the amount and variety of non-[[collagen]]ous proteins in bone is altered. Osteoporosis is defined by the [[World Health Organization]] (WHO) in women as a bone mineral density 2.5 [[standard deviation]]s below peak bone mass (20-year-old sex-matched healthy person average) as measured by [[Dual energy X-ray absorptiometry|DXA]]; the term "established osteoporosis" includes the presence of a [[fragility fracture]].<ref name=WHO1994>{{cite journal |author=WHO |title=Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group |journal=World Health Organization technical report series |volume=843|issue= |pages=1–129 |year=1994 |pmid=7941614 |doi=}}</ref> | ||
| Line 22: | Line 23: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Disease]] | |||
[[Category:Geriatrics]] | |||
[[Category:Aging-associated diseases]] | |||
[[Category:Endocrinology]] | |||
[[Category:Radiology]] | |||
[[Category:Skeletal disorders]] | |||
[[Category:Orthopedics]] | |||
Latest revision as of 16:44, 2 November 2012
|
Osteoporosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Medical Therapy |
|
Case Studies |
|
Osteoporosis classification scheme On the Web |
|
American Roentgen Ray Society Images of Osteoporosis classification scheme |
|
Risk calculators and risk factors for Osteoporosis classification scheme |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Raviteja Guddeti, M.B.B.S.[3]
Overview
Osteoporosis is defined as a disease state with a T-score of less than -2.5 for decreased bone mineral density on a DEXA scan. Osteoporosis may be primary (without any underlying cause) or secondary (having an underlying cause).
Classification
There are three types into which osteoporosis is sub-divided. They are:
- Involutional Osteoporosis - otherwise called primary osteoporosis. No underlying cause is identified.
- Secondary osteoporosis in which the underlying cause (eg, steroid use) is known.
- Rare forms of the disease, such as juvenile, pregnancy-related, and postpartum osteoporosis.
There is a spectrum of disease ranging from osteopenia (milder and earlier bone loss) to osteoporosis (later more severe bone loss).
Osteopenia
Osteopenia which is defined as bone mineral density ranging from less than -1.0 and more than -2.5, can be a precursor condition to osteoporosis.[1]
Osteoporosis
In osteoporosis the bone mineral density (BMD) is reduced, bone microarchitecture is disrupted, and the amount and variety of non-collagenous proteins in bone is altered. Osteoporosis is defined by the World Health Organization (WHO) in women as a bone mineral density 2.5 standard deviations below peak bone mass (20-year-old sex-matched healthy person average) as measured by DXA; the term "established osteoporosis" includes the presence of a fragility fracture.[2]
References
- ↑ WHO Scientific Group on the Prevention and Management of Osteoporosis (2000 : Geneva, Switzerland) (2003). "Prevention and management of osteoporosis : report of a WHO scientific group" (pdf). Retrieved 2007-05-31.
- ↑ WHO (1994). "Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group". World Health Organization technical report series. 843: 1–129. PMID 7941614.